Autor: |
Mayer-Hamblett N; Cystic Fibrosis Therapeutics Development Network Coordinating Center, Seattle Children's Hospital, Seattle, Washington.; Department of Pediatrics and.; Department of Biostatistics, University of Washington, Seattle, Washington., Nichols DP; Cystic Fibrosis Therapeutics Development Network Coordinating Center, Seattle Children's Hospital, Seattle, Washington.; Department of Pediatrics and., Odem-Davis K; Cystic Fibrosis Therapeutics Development Network Coordinating Center, Seattle Children's Hospital, Seattle, Washington., Riekert KA; Division of Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland., Sawicki GS; Division of General Pediatrics and Respiratory Diseases, Boston Children's Hospital, Boston, Massachusetts.; Department of Pediatrics, Harvard Medical School, Harvard University, Boston, Massachusetts., Donaldson SH; Division of Pulmonary and Critical Care Medicine and., Ratjen F; Division of Respiratory Translational Medicine Program, SickKids Research Institute, Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.; Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada., Konstan MW; Department of Pediatrics, Rainbow Babies and Children's Hospital and School of Medicine, Case Western Reserve University, Cleveland, Ohio., Simon N; Cystic Fibrosis Therapeutics Development Network Coordinating Center, Seattle Children's Hospital, Seattle, Washington.; Department of Biostatistics, University of Washington, Seattle, Washington., Rosenbluth DB; Division of Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine, Washington University, St. Louis, Missouri., Retsch-Bogart G; Division of Pediatric Pulmonology, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina., Clancy JP; Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.; Cystic Fibrosis Foundation, Bethesda, Maryland., VanDalfsen JM; Cystic Fibrosis Therapeutics Development Network Coordinating Center, Seattle Children's Hospital, Seattle, Washington., Buckingham R; Cystic Fibrosis Therapeutics Development Network Coordinating Center, Seattle Children's Hospital, Seattle, Washington., Gifford AH; Pulmonary and Critical Care Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire; and.; The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire. |